Skip to main content
Clinical Trials/NCT02456194
NCT02456194
Completed
Not Applicable

Management of Traumatic Bone Defects in Tibial Plateau Fractures With Antibiotic-Impregnated Biodegradable Calcium Sulfate Beads: A Prospective Clinical Trial

Ross Leighton5 sites in 1 country30 target enrollmentSeptember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tibial Fractures
Sponsor
Ross Leighton
Enrollment
30
Locations
5
Primary Endpoint
Resorption of Study Device
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This is a prospective clinical trial of tibial plateau fractures treated with internal fixation and a calcium sulfate graft which can be mixed with antibiotics and molded into various bead sizes for implantation into bone defects. The graft material chosen for this study is STIMULAN Rapid Cure (Biocomposites, UK), which is approved for use as a bone void filler and may be mixed with a variety of antibiotics. The combination of STIMULAN + antibiotic in bead form is the "study device".

Our primary study aim is to look at resorption and remodeling of the study device into bone. Another important aim of the study is to look at subsidence, or collapse, of the joint surface.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
May 2021
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Ross Leighton
Responsible Party
Sponsor Investigator
Principal Investigator

Ross Leighton

Orthopaedic Surgeon

Nova Scotia Health Authority

Eligibility Criteria

Inclusion Criteria

  • Adult (skeletally mature) men or women;
  • Acute, closed, tibial plateau fractures, Schatzker grade 1 through 5;
  • Internal fixation and use of study device per protocol;
  • Fracture repair within 30 days of injury;
  • Signed informed consent to participate in study.

Exclusion Criteria

  • Uncontrolled diabetes;
  • Severe degenerative or metabolic bone disease;
  • Malignancy;
  • Severe vascular or neurologic disease;
  • Alcoholism;
  • Substance abuse;
  • Use of systemic steroids;
  • Immunosuppressive therapy;
  • Hypercalcaemia;
  • Renal-compromised patients;

Outcomes

Primary Outcomes

Resorption of Study Device

Time Frame: 6 months

Number of participants with any study device remaining visible on CT

Secondary Outcomes

  • Knee Injury Osteoarthritis Outcome Score - Quality of Life Subscale(12 months)
  • Resorption of Study Device(12 months)
  • Knee Injury Osteoarthritis Outcome Score - Pain Subscale(12 months)
  • Range of Motion(12 months)
  • Subsidence of Joint Surface(6 weeks, 3 months, 6 months, 12 months)
  • Knee Injury Osteoarthritis Outcome Score - Symptoms Subscale(12 months)
  • Knee Injury Osteoarthritis Outcome Score - Activities of Daily Living Subscale(12 months)
  • Knee Injury Osteoarthritis Outcome Score - Sports/Recreation Subscale(12 months)

Study Sites (5)

Loading locations...

Similar Trials